Natixis’s Calumet Specialty Products CLMT Stock Holding History

Natixis’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31K	Buy	+92	New	+$3.09K	﹤0.01%	1104
2020 Q2	–	Sell	-52,700	Closed	-$55K	–	749
2020 Q1	$55K	Hold	52,700	–	–	﹤0.01%	680
2019 Q4	$192K	Buy	+52,700	New	+$182K	﹤0.01%	812
2019 Q1	–	Sell	-20,900	Closed	-$46K	–	795
2018 Q4	$46K	Buy	+20,900	New	+$86.2K	﹤0.01%	677
2013 Q4	–	Sell	-200,000	Closed	-$5.46M	–	565
2013 Q3	$5.46M	Hold	200,000	–	–	0.06%	229
2013 Q2	$7.28M	Buy	+200,000	New	+$7.19M	0.1%	165

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Natixis's CLMT Position: Q2 2026 in Review

Natixis opened a new position in Calumet Specialty Products (CLMT) in Q2 2026: 92 shares worth $3.31K. The stake represents ﹤0.01% of the portfolio and ranks #1104 among its holdings. This is a return to the name: Natixis previously reported a position in CLMT as recently as Q1 2020.

Natixis first reported a position in CLMT in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.28M in Q2 2013. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Natixis held 92 shares of Calumet Specialty Products worth $3.31K as of Q2 2026.
Calumet Specialty Products was a new Natixis position in Q2 2026.
Calumet Specialty Products made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #1104 holding.
Natixis first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 6 quarters since.
Natixis's Calumet Specialty Products position peaked at $7.28M in Q2 2013.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.